Should I buy Akamai Technologies (AKAM) stock or is it too late?
⭐ The most reliable of them, either direction: DA Davidson — 74% of its targets hit on this sector (174 calls tested). It aims for $150 (+50 %), call made on October 1, 2026, maturing on October 1, 2027 (13 d ago).
Firm-by-firm track record on Akamai Technologies
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B. Riley Securities | 100 % | +20.6 % | 9 | $125 +25% |
| Scotiabank | 43 % | +20.3 % | 7 | $180 +80% |
| Evercore ISI Group | 62 % | +14.2 % | 8 | $175 +75% |
| Craig-Hallum | 86 % | +8.6 % | 7 | $125 +25% |
| Morgan Stanley | 73 % | +6.0 % | 11 | $165 +65% |
| Keybanc | 61 % | +5.9 % | 18 | $195 +95% |
| Piper Sandler | 56 % | +5.3 % | 16 | $158 +58% |
| JP Morgan | 67 % | +4.7 % | 15 | $167 +67% |
✅ Reasons to believe
- Median price target $154, i.e. +54% from the current price ($100).
- The most reliable firm on AKAM, Morgan Stanley (73% hit rate, 11 scored calls), targets $165 (call made on May 14, 2026, maturing on May 14, 2027) (+65%) in its most recent call, and $115 (call made on January 12, 2026, maturing on January 12, 2027) (+15%) in the one coming due soonest.
- 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 16 ratings, 7 are neutral.
- High valuation (P/E ~36): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on AKAM
Median target $154 (+54%) · 16 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Akamai Technologies now?
We won't decide for you. The facts: 56% of analysts rate it a buy, median target $154 (+54%), and Morgan Stanley (most reliable on AKAM, 73%) targets $165. Weigh that against valuation (P/E ~36) and volatility. This is not personalized advice.
Is it too late to invest in Akamai Technologies?
Not according to analysts: the median target ($154) is still +54% above the current price ($100) (most reliable on AKAM: Morgan Stanley, 73%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Akamai Technologies still worth investing in?
It depends on the gap between the price ($100) and its estimated value: analysts target $154 on median (+54%), with 56% buys (most reliable on AKAM: Morgan Stanley, 73%). Cross-check with their real reliability on AKAM and the cautions above. Information, not advice.
What's the main risk in buying AKAM?
The consensus is not unanimous: of 16 ratings, 7 are neutral.
→ Go deeper: the full Akamai Technologies profile (consensus, analyst reliability, price target, performance).